HCPCS Code J3241: Injection, Teprotumumab-trbw, 10 mg

HCPCS Code J3241: Injection, Teprotumumab-trbw, 10 mg

Learn all about HCPCS code J3241 for injection, teprotumumab-trbw, 10 mg, through this short guide.

Use Code
## **What is the HCPCS code J3241 for?** The HCPCS code J3241 is for an injection of teprotumumab-trbw, specifically a dosage of 10 mg. The purpose of this injected medicine is to treat active thyroid eye disease (thyroid-associated ophthalmopathy) that emerges as a result of problems like Graves' disease. What this intravenous medication does is reduce the effects of inflammation and the size of swelling. It reduces proptosis and double vision as well. Whether you're about to inject an initial dose or your patient is back for subsequent infusions, don't forget standard clinical practice guidelines and prepare the IV drip setup, teprotumumab, and vital signs monitoring equipment so you can properly administer the medicine and observe the patient for any adverse reactions. Make sure you apply proper medical management for allergic reactions (if any) and blood sugar levels.
## **Documentation requirements for J3241** As with any procedure, especially involving injecting drugs into patients, it's important to document the following before you file for a claim that includes this code: - The full name of the personnel who administered the injection + their credentials - The name and address of the facility where the injection was administered - The full name of the patient - The date and time of the drug administration by injection - Patient records showing they have been diagnosed with thyroid eye disease - Blood test results that show thyroid function-related information - Any CT or MRI scans of their eye anatomy, especially if there's eye bulging - The exact dosage
## **Billing requirements for J3241** Besides the documentation requirements above, please note the following billing guidelines for this HCPCS code: - They must reflect the dosage given throughout the treatment. - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication. Since this is a type of medicine administered via intravenous infusion, please make sure that the CPT code 96365 accompanies all the other codes you're using. Make sure to always follow medical policies related to all these codes as mandated by the CMS.
## **Other similar codes** - J3101 - Injection, tenecteplase, 1 mg - J3111 - Injection, romosozumab-aqqg, 1 mg - J3145 - Injection, testosterone undecanoate, 1 mg - J3243 - Injection, tigecycline, 1 mg - J3245 - Injection, tildrakizumab, 1 mg

Frequently asked questions

In general, even if medicines have undergone numerous clinical trials, it's important to know that they will still have risks even after being approved. For this medicine in particular, common risks include pain in the IV site, headaches, and muscle spasms. The worst reactions include allergic reactions and hyperglycemia (which is why we mentioned earlier that you have to monitor and manage the blood sugar levels of the patient). It's also possible for them to have hearing problems.

No. It's important for patients to get this injection over the course of multiple sessions. The benefits will only start showing after a few repeat visits.

They can take oral corticosteroids instead. They can also opt for orbital radiotherapy or orbital decompression surgery.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments